HealthBank Holdings Limited (SGX:40B)
Singapore · Delayed Price · Currency is SGD 0.0550
+0.0050 (10.00%)
At close: Sep 3, 2026
HealthBank Holdings Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.14 | 0.14 | 0.19 | 0.23 | 0.38 | 0.1 |
| 0.14 | 0.14 | 0.19 | 0.23 | 0.38 | 0.1 | |
Revenue Growth | -24.02% | -25.53% | -16.81% | -40.37% | 282.83% | - |
Cost of Revenue | 0.7 | 0.66 | 0.83 | 1.14 | 1.45 | 1.84 |
Gross Profit | -0.56 | -0.52 | -0.64 | -0.91 | -1.07 | -1.74 |
Selling, General & Admin | 0.89 | 0.89 | 1.22 | 0.4 | 0.35 | 0.5 |
Other Operating Expenses | 0.6 | 0.4 | 0.45 | 1.17 | 2.16 | 1.53 |
Operating Expenses | 1.49 | 1.3 | 1.67 | 1.57 | 2.51 | 2.03 |
Operating Income | -2.06 | -1.81 | -2.31 | -2.48 | -3.59 | -3.77 |
Interest Expense | -0.04 | - | -0 | -0 | -0.36 | -1.01 |
Interest & Investment Income | - | - | - | - | - | 0.03 |
Currency Exchange Gain (Loss) | - | -0.02 | -0.09 | -0.35 | -0.85 | 0.72 |
EBT Excluding Unusual Items | -2.1 | -1.83 | -2.4 | -2.83 | -4.8 | -4.03 |
Gain (Loss) on Sale of Investments | -5.62 | -1.46 | -1.92 | -32.56 | -6.13 | - |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.6 | 0 |
Other Unusual Items | - | - | -3.9 | -0.7 | -0.85 | 0.17 |
Pretax Income | -7.72 | -3.29 | -8.22 | -36.08 | -11.18 | -3.86 |
Earnings From Continuing Operations | -7.72 | -3.29 | -8.22 | -36.08 | -11.18 | -3.86 |
Net Income to Company | -7.72 | -3.29 | -8.22 | -36.08 | -11.18 | -3.86 |
Minority Interest in Earnings | 0.06 | 0.06 | 0.05 | 0.06 | 0.05 | 0.21 |
Net Income | -7.66 | -3.23 | -8.17 | -36.02 | -11.13 | -3.64 |
Net Income to Common | -7.66 | -3.23 | -8.17 | -36.02 | -11.13 | -3.64 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 110 | 96 | 94 | 94 | 82 | 78 |
Shares Outstanding (Diluted) | 110 | 96 | 94 | 94 | 82 | 78 |
Shares Change | 16.75% | 1.71% | - | 15.65% | 4.53% | - |
EPS (Basic) | -0.07 | -0.03 | -0.09 | -0.38 | -0.14 | -0.05 |
EPS (Diluted) | -0.07 | -0.03 | -0.09 | -0.38 | -0.14 | -0.05 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -5.8 | -1.91 | -2.42 | -2.74 | -3.26 | -4.15 |
Free Cash Flow Per Share | -0.05 | -0.02 | -0.03 | -0.03 | -0.04 | -0.05 |
Gross Margin | - | - | - | - | -283.38% | - |
Operating Margin | -1511.76% | -1294.29% | -1226.60% | -1096.90% | -946.17% | -3810.10% |
Profit Margin | -5633.09% | -2310.00% | -4345.21% | -15938.94% | -2936.94% | -3679.80% |
Free Cash Flow Margin | -4263.97% | -1365.00% | -1287.23% | -1210.18% | -859.63% | -4191.92% |
EBITDA | -2.05 | -1.81 | -2.3 | -2.48 | -3.58 | -3.77 |
D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -2.06 | -1.81 | -2.31 | -2.48 | -3.59 | -3.77 |
Revenue as Reported | - | - | - | - | -6.38 | 0.72 |